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OVERVIEW — This background paper examines approaches to delivering and
financing health services for persons with advanced chronic illness. Recogniz-
ing that the Medicare program is the major insurer of such services and that
its share is likely to increase due to the aging of the population, the paper
focuses on the nature and structure of Medicare hospice—and, to a very lim-
ited extent, palliative-care—benefits. It also explores Medicaid benefits, as well
as coverage through private insurance, including indemnity, point-of-service,
and preferred-provider-organization products. In addition to giving descrip-
tive information on the various programs, the paper looks at quality concerns
and cost and payment considerations.
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Managing Advanced Illness:
A Quality and Cost Challenge
to Medicare, Medicaid, and
Private Insurers
Advanced illness is a challenge to this country’s “cure-all” culture of
high-technology procedures and newly discovered drugs. Persons with
advanced chronic diseases that will soon end their lives tend to repre-
sent failure to the health care system. But as the population ages, the
definition of “success” in caring for persons with advanced illness is
gradually taking on new meaning: the degree to which the quality of
patients’ lives is enhanced and their suffering relieved.
Educating patients about the disease process and prognosis is integral
to success, so that treatment can be provided throughout the care con-
tinuum according to the preferences of patients and family members.
When advanced illness means that death in the near term is likely, un-
derstanding how patients want to spend the rest of their lives is crucial.
This is true not only for the patients themselves but also for the provid-
ers responsible for recommending and implementing patient care plans
and the payers responsible for managing the plans’ costs. It is also im-
portant for policymakers in both the public and private sectors, as they
change their focus from a procedure- and pharmacy-oriented inpatient
and outpatient health care system to a continuum of preventive, ambu-
latory, inpatient, and post-acute care for those with chronic illness.
While advanced illness obviously is not limited to those 65 years of age
and older, the 65-plus population consumes one-third of health care spend-
ing and one-half of physician time in the United States, according to the
Alliance for Aging Research. Nearly three-quarters of the people who die
each year in this country are in that age group. For most, the cause of
death is a chronic disease, with heart disease, cancer, stroke, and chronic
obstructive pulmonary disease (COPD) topping the list. Despite medical
advances, death from advanced chronic illness takes its toll, although the
age of death is being extended.1 By the time the baby-boom generation,
consisting of those born between 1946 and 1964, starts reaching age 65,
“the 35 million Americans over 65 today will double in size, approaching
one quarter of the population.” By mid-century, the number of those over
85 will nearly quadruple.2
“The elderly with chronic diseases often face a period of decline in health
and function before death that—with the exception of cancer—varies
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significantly in duration and symptomology from patient to patient,”
James Lubitz, Ph.D., of the Centers for Medicare and Medicaid Services
(CMS) indicates. Pointing out that some persons want “continued inten-
sive, invasive efforts,” while others reject them, he goes to the crux of the
matter: “I would prefer to see a financing system that was capable of
respecting both courses of action—one that allows for this kind of pa-
tient-directed action.”3
In a recent study, “persons who were 60 years of age or older and who had
a limited life expectancy due to cancer, congestive heart failure (CHF), or
COPD,” gave their preferences based on their understanding of the out-
comes of treatment. If treatment placed a low burden on them and restored
their health, 98.7 percent said they would choose to receive it. However, if
the treatment resulted in their survival but with severe functional impair-
ment, 74.4 percent indicated they would not choose it. If the treatment meant
they would survive but with severe cognitive impairment, an even higher
proportion—88.8 percent—would choose not to have it.4
Even those who reject “intensive, invasive efforts” if the likelihood of cog-
nitive or functional impairment is high may wish to have a menu of choices,
a range of options regarding their care. This half of the equation tends to be
forgotten, implying that the opposite of turning down intensive, invasive
measures is a void. While some patients’ care may be restricted to symp-
tom management, prescribing and monitoring of medications, and provi-
sion of psychological and social support, others’ treatment may include
“interventions designed to improve their physical, functional, emotional,
and social well-being.” This was the case in clinical trials of seriously ill
cancer patients at the University of California at Davis. The patients re-
ceived both investigational chemotherapy and palliative care. According
to Frederick J. Meyer, M.D., professor and chair of internal medicine at UC
Davis, “In the past, it’s been an either-or situation....In our opinion, that’s
not an acceptable choice. Why can’t patients have both?”5
Some patient advocates, health professionals, and health plan adminis-
trators have addressed the need to help patients and families thread their
way—through various transitions—toward appropriate end-of-life care.
They have redefined success in caring for those with advanced illness in
innovative ways that strive for continuity of patient education, continu-
ity of patient care, and continuity of patient and family support. The
models that they have developed, however, face numerous barriers in
the delivery and financing of services because of the compartmentaliza-
tion and rigidity of the health care infrastructure itself. Rather than en-
couraging continuous and simultaneous services that address the needs
of patients—services that may modify patients’ courses of illness with-
out being curative—delivery and payment policies tend to discourage
them. Such barriers raise important questions for policymakers: How can
the health “system,” known for its fragmentation and inflexibility, respond
to patients who clearly are concerned with the quality of the time they
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have remaining? How can health care financing—particularly Medicare,
which pays for most end-of-life services—allow for such quality to be
recognized and supported?
HOSPICE: FORERUNNER OF A BROADER
PALLIATIVE-CARE BENEFIT?
For the past 25 years or so, end-of-life care has largely been associated
with hospice services, even though only about a fifth of those who die of
advanced illness actually avail themselves of hospice benefits through
Medicare, Medicaid, or private insurance. While hospice itself is a far-
reaching concept, the hospice benefit—as offered by public and private
insurers—tends to be fairly restrictive. Hospice is defined by the National
Hospice and Palliative Care Organization (NHPCO) as
a team-oriented approach of expert medical care, pain management, and
emotional and spiritual support expressly tailored to the patient’s wishes.
Emotional and spiritual support also is extended to the family and loved
ones. Generally, this care is provided in the patient’s home or in a home-
like setting operated by a hospice program.6
Some Background
From a public policy standpoint, federal research and development of stan-
dards and payments for hospice care were the first acknowledgments of
the need for a new approach to care of the dying in this country. Federal
support for hospice dates to the mid- to late 1970s, when the National Can-
cer Institute funded studies at the Connecticut Hospice in New Haven and
at hospices in Arizona, California, and New Jersey. A federal task force
issued a report in 1978 on the role of the federal government in providing
hospice services and, that same year, the Health Care Financing Adminis-
tration (HCFA), now CMS, of the U.S. Department of Health and Human
Services (DHHS), announced that it would support demonstration projects
on providing health services to persons with terminal illnesses. The U.S.
General Accounting Office (GAO) followed up in 1979 with a report profil-
ing hospice services and outlining requirements for them, particularly un-
der HCFA programs. In 1980, under Medicare and Medicaid waivers, HCFA
began paying 26 hospice providers for home health services, as well as for
bereavement counseling and pain-control drugs.
Charitable foundations played a large role in these early developments.
The Robert Wood Johnson Foundation (RWJF) and the John A. Hartford
Foundation helped finance the assessment of HCFA’s demonstration pro-
gram, and the W. K. Kellogg Foundation provided funding to the Joint
Commission on Accreditation of Hospitals (now the Joint Commission
on Accreditation of Healthcare Organizations) for preparation of a hos-
pice standards manual and an assessment and survey guide, both of which
were published in 1983.
While hospice itself is a
far-reaching concept, the
hospice benefit tends to
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5NHPF Issue Brief No.779 / June 20, 2002
By 1983, relying on charitable contribu-
tions, private insurance dollars, and self-
pay patients, 1,145 programs had de-
fined themselves as hospices. (In 2000,
there were 3,100 programs, which ad-
mitted 700,000 patients, according to
NHPCO.)7 On November 1, 1983, the
federal government started to pay for
hospice services. Without waiting for
the final results of the assessment and
research studies, Congress had autho-
rized hospice coverage under Medicare
in the Tax Equity and Fiscal Responsi-
bility Act of 1982, with an expiration date
of October 1, 1986. Subsequent legisla-
tion, the Consolidated Omnibus Bud-
get Reconciliation Act of 1985 (COBRA),
eliminated the sunset clause.
The Medicare hospice provisions served
as guidelines for hospice services under
Medicaid, the Civilian Health and Medi-
cal Program of the Uniformed Services
(CHAMPUS), and the Veterans Admin-
istration (now the Department of Vet-
erans Affairs). COBRA authorized hos-
pice coverage as an optional state ben-
efit for Medicaid, and a Department of
Defense measure that became law in
1991 provided for hospice care in mili-
tary hospitals for active-duty personnel
and in the CHAMPUS program for mili-
tary dependents. Around the same time,
the Veterans Administration began of-
fering hospice services.
Medicare Hospice Benefit as
Model
As the Medicare hospice benefit evolved
over the years, it took on the following
standards:8
■ It is available as a benefit under
Part A of the Medicare program.
Under the benefit, “beneficiaries elect
to receive non-curative treatment and
services for their terminal illness by
HOSPICE STATISTICS 2000
(For 3,100 Operational Hospice Programs in the United States,
Including the District of Columbia, Puerto Rico, and Guam)
Hospice Ownership
Nonprofit 73%
For-Profit 20%
Government-Operated 7%
Hospice Medicare Certification
Certified 91%
Not Certified 9%
Freestanding, Affiliated, and Other Hospices a
Freestanding 37%
Affiliated 66%
With Hospitals 35%
With Home Health Agencies 22%
With Hospital Systems 9%
Other 6%
Hospice Geographic Location
Rural 49%
Urban and Rural 38%
Urban 13%
Hospice Days of Service b
Routine Home Care 96%
Inpatient Care 3%
Respite Care 0.3%
Continuous Home Care 0.3%
Hospice Days of Service by Payer b, c
Medicare 79%
Private Insurance 13%
Medicaid 5%
Alternative Sources 3%
Self-Pays 1%
a Does not add up to 100% due to an overlap.
b Does not add up to 100% due to rounding.
c Hospice providers gained additional funds from charitable contributions.
Source: National Hospice and Palliative Care Organization, “NHPCO Facts and
Figures”; accessed May 24, 2002, at http://www.nhpco.org/.
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waiving the standard Medicare benefits for treatment of a terminal
illness.” Beneficiaries may, however, still receive standard Medicare
benefits for the treatment of conditions that are not related to the
terminal illness.
■ It is accessible to Medicare beneficiaries who “are certified by their
doctor and the hospice medical director as terminally ill” and who
“have a life expectancy of six months or less.” A beneficiary must sign a
statement choosing the benefit over curative treatment and enroll in a
Medicare-approved hospice program.
■ It mandates services relating to the terminal diagnosis, as outlined in
the beneficiary’s care plan, by physicians for medical direction of the
patient’s care, registered and licensed practical nurses through regular
home care visits, home health aides and homemakers, and chaplains. It
also includes social work and counseling services, bereavement coun-
seling, medical equipment, medical supplies, drugs for symptom
control and pain relief, volunteer support, medical rehabilitation
services (by physical and occupational therapists and speech patholo-
gists), and dietary counseling. The inclusion of outpatient prescription
drugs is unique for a Medicare benefit. A family member or other
person who is significant to the patient serves as the primary caregiver
and, when appropriate, helps make decisions for the patient. Hospice
staff members are on call 24 hours a day, seven days a week.
■ While mainly provided in a home setting, it reimburses for services
delivered in freestanding hospice facilities and hospitals, as well as in
nursing homes and other long-term-care facilities. Medicare provides
a capitated per diem payment for almost all services the patient
receives. The patient is responsible for a 5 percent copayment for
respite care and up to $5 for each prescription. Medicare does not
cover room and board, but Medicaid may pick up those costs for its
beneficiaries.
■ In statutory language, it lasts as long as the patient’s physician
recertifies the terminal illness. As long as the patient is eligible, two 90-
day periods of care are followed by an unlimited number of 60-day
periods. CMS, however, has the policy of continuing the benefit “as
long as the patient shows objective evidence of clinical decline,” which
has to be documented.9 Because the prognosis is expected to be six
months or less, extensive stays tend to garner suspicion from federal
inspectors.
Inherent Problems
While hospice was first heralded as the gold standard of end-of-life care,
it soon encountered criticism from hospice providers and patients, who
found the benefit too rigid, and from government, which undertook fraud
investigations. Providers of end-of-life care are concerned about what
they call “the irrational choice” patients face in being required to forgo
While hospice was
first heralded as the
gold standard of end-
of-life care, it soon en-
countered criticism.
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curative care in order to access hospice services. “The either-or approach
that was adopted as a cost containment measure imposes a simplistic
binary-decision model that is not consistent with either the clinical or
emotional reality of the hospice process for patients and their families,”
according to David Rehm, president and chief executive officer of
VistaCare Hospice Foundation.10
“When patients are most vulnerable, they have to choose between a
hospice model that can cut them off from the professionals who are
treating them and a curative model that may be highly inappropriate
for their care,” Diane Meier, M.D., director of the Mount Sinai School of
Medicine Center to Advance Palliative Care, indicates. “The rational
approach would be to continue disease-modifying treatment as well as
palliative care. The same professionals, the same team, would continue
caring for the patient and the transitions would be seamless.”11
The DHHS Office of Inspector General (OIG), on the other hand, has
been concerned about enforcement of hospice rules, particularly of the
six-month prognosis requirement. The OIG conducted numerous audits
of Medicare hospice services during the mid- to late 1990s to see if the
rules were being followed. The office’s concerns centered on whether
or not the beneficiaries, especially those with diagnoses other than can-
cer, met the definition of “terminally ill” when they enrolled in hospice
programs.12 Critics of the OIG have accused the office of unreasonably
expecting “people to die on time.” For example, the Wall Street Journal
headlined a 2000 story: “Rules Are Rules: Hospice’s Patients Beat the
Odds, So Medicare Decides to Crack Down.”13
The Balanced Budget Act of 1997 addressed some of the OIG concerns
by permitting hospices to discharge patients who improved, without
eliminating their future benefits, and by requiring recertification of hos-
pice patients every 60 days (after the first 180 days). However, these
provisions did not dispel criticism by hospice providers and their advo-
cacy groups that the hospice benefit, as defined, was inflexible. Hospice
providers—such as the National Hospice Work Group, a national orga-
nization of major not-for-profit hospice providers—contend that the
benefit, as defined, is not working as it was intended. Because of the
six-month prognosis requirement, hospice predominately draws those
with advanced chronic illnesses with fairly certain trajectories, such as
certain cancers, and not those—such as persons with COPD—with less
predictable courses of illness.
Probably because of the “either-or” hospice option and the difficulty of
predicting death with exactitude, dying persons are entering into hos-
pice too late, providers believe. While NHPCO cited an average length of
service of 64 days in its 1992 census, it indicates that the mean fell to 48
days in 2000. NHPCO contends that the median length of service, which
was 25 days in 2000, is more accurate because of the high frequency of
short periods of service. A third of those who were served by hospice in
 HOSPICE DEMOGRAPHICS
IN 2000
Gender
Female 55.0%
Male 45.0%
Age*
17 & younger 0.4%
18-34 1.0%
35-64 17.0%
65-74 24.0%
75-84 33.0%
85 & older 25.0%
Race / National Origin
White/Anglo 82.0%
Black/African-American 8.0%
Latino/Hispanic 2.0%
Other 2.0%
Not Classified 6.0%
* Slightly over 100% due to rounding.
Source: National Hospice and Palliative
Care Organization, “NHPCO Facts and
Figures”;  accessed May 24, 2002, at
http://www.nhpco.org/.
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2000 died in seven days or fewer.14 Moreover, a GAO study issued in
2000 indicates that, “although more beneficiaries are choosing hospice,
many are doing so closer to the time of death. Half of Medicare hospice
users are enrolled for 19 or fewer days, and service periods of one
week or less are common.”15 In publicizing these numbers, providers
say that the OIG assessments were skewed, because the OIG audits
targeted lengths of service over 210 days (and largely in nursing facili-
ties, where Medicare hospice services are available only to patients who
are also eligible for Medicaid or who have private-pay status).
Providers also express concern that OIG activities have had a chilling
effect on physicians unfamiliar with the hospice concept or reluctant to
refer patients to hospice. They cite the lack of training in palliative medi-
cine at both the undergraduate and graduate levels and the absence of
requirements to mandate it. In addition, they have asserted that the per
diem rates and aggregate caps on hospice payments, while encouraging
cost-effective care, may be inadequate for certain patients. “The develop-
ment of many new higher-cost and higher-technology pain and symp-
tom treatments that were never anticipated in the cost structure of the
original benefit has exerted cost pressure on the per diem rates,” Rehm of
VistaCare indicates. “The result of this antiquated cost structure is that
many smaller hospice providers are forced to limit admission to those
that are unlikely to require these treatments.”16
Providers that are involved in both hospice and palliative care have
indicated that, if the restrictive barriers to fuller utilization of the hos-
pice service system were corrected, the hospice program would be con-
siderably more effective. While they see the need for an expanded pal-
liative care benefit, they think it should be paired with improvement of
hospice, because most palliative care to date has been hospital-based.17
Cynthia Pan, M.D., assistant professor of geriatrics at Mount Sinai, has
identified over 400 hospitals with palliative care programs.
The Palliative Care Approach
While some leading providers in the field of end-of-life care are com-
mitted to improving the hospice benefit, others prefer a broader pallia-
tive care program. One of the original advocates of palliative care, the
Cleveland Clinic, defines the term in this way:
The word palliative is derived from the Latin pallium, a cloak or cover.
Thus, palliative care is a form of care that (a) recognizes that cure or
long-term control is not possible, (b) is concerned with the quality rather
than quantity of life, and (c) cloaks troublesome and distressing symp-
toms with treatments whose primary or sole aim is the highest possible
measure of patient comfort....
The goal of palliative care is fully realized, however, only if attention
is given to all of the following: (a) relief for the patient from pain and
other distressing symptoms, (b) psychological and spiritual care for
Some leading providers
in the field of end-of-life
care are committed to
improving the hospice
benefit, but others pre-
fer a broader palliative
care program.
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the patient, (c) a support system to help the patient live as actively as
possible in the face of impending death, and (d) a support system to
sustain the patient’s family during the illness and bereavement.18
A study by the Mount Sinai School of Medicine Center to Advance Pal-
liative Care—supported by RWJF—indicates that such a program would
be available to “the chronically sick with conditions such as heart or
lung disease who are not expected to survive more than a few years,” as
well as to “the ‘actively dying,’ whose anticipated life expectancy is
measured in days or weeks.” Ironically, as those urging a broader model
seek to break the bonds that the hospice benefit imposes on them, they
recognize that Medicare “currently pays for palliative care services per
se only within the hospice benefit.”19 According to Meier, of the Mount
Sinai School of Medicine Center to Advance Palliative Care,
The biggest challenge—and one that continues to plague even success-
ful palliative care programs like that at Mount Sinai—is money, or
rather the lack thereof. Only about 15 percent of physician and nursing
salaries at Mount Sinai’s palliative care institute are paid through clini-
cal billing. To date, the institute has survived on philanthropy, grants,
and some institutional support—a piecing together of financing that
can hardly be viewed as a sustainable model.20
Meier adds, however, that Mount Sinai has chosen to provide support
for the palliative care program because patients who receive services
under it have shorter lengths of inpatient stay and lower pharmacy costs.
Studies have shown that subsidizing the salaries of the palliative care
interdisciplinary team saves money in other areas, she points out.21
Admittedly, there are no clear definitional lines between hospice and
palliative care, which NHPCO acknowledged in 2000 when it changed
its name from the National Hospice Organization, founded in 1978, to
the National Hospice and Palliative Care Organization.22 (Palliative care
originally was a hospital-based model, and its leadership still comes
largely from the hospital sector, but the term seems to have expanded
to apply to other settings, including the home.) To those who receive,
provide, and pay for services to address advanced illness, the term that
is used may not be as important as the quality of life that is achieved
and the cost resources that are allocated. From a policy standpoint, ac-
cess to a broader benefit may well depend upon how well advocates of
a new advanced-illness care model are able to document that it would
have a positive effect on patients’ quality of life and be a cost-effective
approach for public and private insurers.
In linking services to payment, some point to the federal government’s
1996 addition of a new diagnosis code for palliative care to the Interna-
tional Classification of Diseases, 9th Revision, Clinical Modification, to enable
hospital coders to indicate that palliative care is provided to a dying pa-
tient during a hospital stay. The code is for research, not payment, so it
does not provide incentives for hospitals to provide palliative care. More-
over, those, such as Meier, who back a comprehensive, integrated model
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of palliative care object to the limitations that one code denotes. The
Center to Advance Palliative Care would like to see development of “a
code for an extended visit in an office, in a hospital, or in a nursing
home for planning end-of-life care (to be paid with appropriate limits
on the frequency of use for any one patient).”23
Addressing Medicare inpatient payment policy, Charles F. von Gunten,
M.D., Ph.D., and several colleagues recently suggested adjusting “hospi-
tal payments to include essential palliative care services for hospitalized
patients in pertinent diagnosis-related groups.” Rejecting a new DRG for
palliative care because it would label patients as “palliative” rather than
identify their needs, they present the following argument:
When looking at contemporary patterns of hospitalization, it is clear that
large numbers of patients are admitted because of complications of ad-
vanced progressive chronic illnesses that are incurable and will ultimately
contribute to their death. It is time to acknowledge this, define the best
approaches, and make the relief of suffering and the provision of pallia-
tive care an explicit part of reimbursed hospitalization for relevant DRGs
under Medicare.24
QUALITY OF CARE, QUALITY OF LIFE
The SUPPORT Study and a Change of Course
Whether the term or concept is “hospice,” “palliative care,” or some-
thing else, such as “transition management,” recognizing and enhancing
the patient’s quality of life is a major feature. The major work on quality
of care and quality of life consists of the “Study to Understand Prog-
noses and Preferences for Outcomes and Risks of Treatment” (SUPPORT)
and a companion study, “The Hospitalized Elderly Longitudinal Project”
(HELP). Initiated in the early 1980s, SUPPORT, developed by Joanne Lynn,
M.D., and William Knaus, M.D., centered on
diagnoses that were common, caused high mortality, engendered im-
portant decisions during hospitalizations (a consideration that elimi-
nated end stage renal failure), and had fairly stable treatment possibili-
ties so that prognostic estimates would be expected to be fairly stable
over the length of the study (a consideration that eliminated HIV/
AIDS). Severity criteria were set so that patients’ average six-month
survival would be 50 percent. Selected diagnoses included acute respi-
ratory failure, COPD, CHF, coma, cirrhosis, advanced colon or non-
small cell lung cancer, and multi-organ system failure, with sepsis or
malignancy.25
By the end of 1999, SUPPORT and HELP had produced extensive data,
including 67 papers published in peer-reviewed journals, on improving
care of those with the diagnoses under study. Additional papers on end-
of-life care were published in 2000, including one on why “an interven-
tion intended to improve decision-making was completely ineffectual.”
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SUPPORT’s thesis was that a patient’s course of care was the result of
interaction between the person’s illness and the decisions—largely made
by physicians—about that care, so that improving decision making at
the patient level would enhance both the process and the outcome for
the patient. Lynn and nine co-authors concluded that
SUPPORT’s intervention may have failed to have an impact because
strong psychological and social forces underlie present practices. Sys-
tem-level innovation and quality improvement in routine care may
offer more powerful opportunities for improvement.26
The conclusion that “the course of care may be determined largely by
pre-existing routine, that patient-centered decision-making is often diffi-
cult to implement, and that improving the experience of patients might
best be achieved by changing institutional and professional routines”27
seems to be guiding experts in end-of-life care now. There is an ongoing
reexamination of “the institutional and professional routines” of those
who care for persons with advanced illness (whether the providers are
primary-care practitioners or specialist physicians) and development of
new models to reform those routines.
Clinician Problems and Ways to Address Them
The study by the Mount Sinai Center to Advance Palliative Care indi-
cates that many clinicians (a) “are uncomfortable talking to their patients
about the inability of contemporary medicine to achieve cure or remis-
sion of their conditions”; (b) “do not manage pain well” and may have
difficulty in managing certain other symptoms (such as “shortness of
breath, anxiety, depression, nausea, and vomiting”); and (c) “are rarely
able to facilitate effective grieving and bereavement for both dying pa-
tients and their families.”28 Because these problems obviously have an
adverse impact on the quality of life of the clinicians’ patients, the au-
thors recommend certain actions:
■ That DHHS modify the Medicare conditions of participation for
hospitals, nursing homes, and home health agencies and that the Joint
Commission on Accreditation of Healthcare Organizations strengthen
its standards for hospitals and other organizations under its purview to
“create an environment in which palliative care is widely understood
and practiced.” That the emphasis be on desired outcomes rather than
on the means by which the outcomes are achieved. That exposure to
standardized end-of-life educational programs for physicians and
nurses should be strongly encouraged or required.
■ That the National Forum for Quality Measurement and Reporting
assure that its measures of hospital quality are consistent with those
developed by the NHPCO for Medicare hospice use.
■ That best practices in the field be identified and disseminated.
■ That Medicare quality improvement organizations (formerly profes-
sional review organizations) “include at least one expert in palliative
There is an ongoing re-
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care on their boards” or have at least one member of the board attend
a recognized palliative-care training program. That the CMS Practicing
Physicians Advisory Council and Medicare carrier advisory commit-
tees also include experts (or in the latter case, train persons) in pallia-
tive care. That CMS advisory committees be evaluated in terms of
whether palliative-care experts should be added.29
The National Consensus Project on Quality Palliative Care is in the pro-
cess of drafting a document on norms and standards for palliative care
and establishing a methodology for diffusion, review, and feedback on
the document. A coalition of five organizations—the American Academy
of Hospice and Palliative Medicine, Center to Advance Palliative Care,
Hospice and Palliative Nurses Association, Partnership for Caring, and
NHPCO—the project has an 18- to 24-month timetable.
Various Collaborations
In the mid-1990s, the American Geriatrics Society developed “domains”
for measuring the quality of care provided to persons at the end of life.
Among them were physical and emotional symptoms, support of func-
tion and autonomy, advance planning, type of care near death (in terms
of the site of death, cardiopulmonary resuscitation, and hospitalization),
patient and family satisfaction, global quality of life (patient’s assessment
of overall well-being), family burden, survival time, provider continuity
and skill, and bereavement.30
Various efforts are now underway to define quality in end-of-life care.
The Outcomes Forum—a joint effort of NHPCO and the National Hos-
pice Work Group—is piloting some outcome measures for hospice that
target “safe and comfortable dying,” “self-determined life closure,” and
“effective grieving.”31 For another example, the United Hospital Fund is
partnering with RAND’s Institute for Healthcare Improvement on the
Palliative Care Quality Improvement Collaborative. The collaborative is
working with 21 hospitals, nursing homes, hospices, and home health
agencies “to improve each organization’s ability to care effectively for
persons with advanced chronic illnesses and those at the end of life.” The
project is targeting pain reduction in palliative-care patients, improved
advance-care planning, better continuity of care between hospital and
nursing home, and better follow-up on referrals for hospice care, through
a process of goal identification, definition of practices to be changed, and
quantifiable measurement of the effectiveness of changes made.32
RWJF has been prominent in funding at least a score of initiatives aimed
at improving end-of-life care, including “Last Acts,” a national coalition
of organizations involved in education, discussion, collaboration, and
dissemination of information to improve services for people who are dy-
ing and their families.33 Numerous other charitable and voluntary orga-
nizations also are working in the field.
Various efforts are
underway to define
quality in end-of-life
care.
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Some Models
Renewed interest in improving the care of persons with chronic illnesses,
particularly those with prognoses of short life expectancies, has stimu-
lated the development of various care models. The Medicare Payment
Advisory Commission (MedPAC) included a chapter on “Care for People
at the End of Life” in its 1998 Report to the Congress: Context for a Changing
Medicare Program, which reviewed some innovative models. The chapter
was innovative in itself, because it represented the commission’s first treat-
ment of the topic. In presenting the chapter, MedPAC indicated:
There is widespread agreement that the quality of care provided at the
end of life is poor. Many studies have found that people do not get the
care they want and that many suffer from high levels of pain due to mis-
communication. Studies also suggest that current payment policies fail
to provide adequate incentives for the provision of palliative care.34
MedPAC cited the United Hospital Fund’s Hospital Palliative Care Ini-
tiative, a precursor of the fund’s Palliative Care Quality Improvement
Collaborative (in partnership with RAND). The initiative was aimed at
improving hospital services for persons who were dying and to encour-
age hospital-based palliative-care programs. It also highlighted the Con-
gestive Heart Failure Case Management Program sponsored by Kaiser
Permanente in Bellflower, California; the multidisciplinary OPTIONS
program developed by the HealthCare Partners Medical Group in Los
Angeles; and the Complex Case Management Program operated by
Franklin Health, Inc., for very ill persons enrolled in managed care plans.
MedPAC also featured MediCaring, a more comprehensive system of
managed care that was proposed by Lynn at the Center to Improve Care
of the Dying, formerly at George Washington University and now at
RAND. Featured in a December 1997 National Health Policy Forum meet-
ing, MediCaring focuses on supportive community-based services that
take into account a patient’s personal preferences, the family’s need for
counseling and support, and the patient’s medical needs.35 It is based on
the premise that good care of the dying calls for interdisciplinary teams,
continuity and coordination of care, integration of diverse services deliv-
ered in a variety of settings, and changes in the orientation of providers.
A model under development at Sutter VNA and Hospice relies on home-
based “transition management” of high-risk, chronically ill patients, in
order to give them better continuity of services until they are eligible and
ready for hospice. If the patients do not elect the hospice benefit or if their
referral is refused, transition management can manage their care. Designed
to fill the gap between the inpatient hospital setting and hospice care
(generally at home), transition management draws upon home-care ser-
vices “to help patients with advanced chronic illness transition smoothly
from acute life-sustaining treatment toward supportive care at home.”36
Brad Stuart, M.D., medical director of Sutter VNA and Hospice indicates:
Renewed interest in
improving the care of
persons with advanced
illnesses has stimulated
the development of
various care models.
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Although many hospice providers (including myself) have tried un-
successfully to help hospice to expand into this role, home care’s po-
tential has not yet been explored. Many patients with advanced illness
are already on home care, yet still need medical services that hospice
cannot easily provide. Hospice will continue to grow, but home care
will probably be where “transition management” will be based, if regu-
lations are changed to allow it.37
Stuart explains that a Medicare-certified home health agency provides
home health services to patients with late-stage illness (or to any other
patients) if they meet the following eligibility criteria: the patient must
be recovering, must be home-bound, and must have a skilled nursing
need. The agency cannot provide hospice services unless it is separately
licensed as a Medicare-certified hospice. (Sutter is both.) However, home
health can follow the patient until he or she no longer has a skilled need,
at which point the agency has to discharge the patient. The patient may
be sufficiently ill to require re-hospitalization or to die within weeks to
months, but may not be “hospice-appropriate.” The reasons for lack of
entry into hospice include having a noncancer diagnosis for which prog-
nosis is uncertain, not being willing to give up all life-sustaining care,
and associating “hospice” with dying.
Just as there is a chasm between “medical model” inpatient treatment
and the Medicare hospice benefit, there is a chasm between home health
and hospice, Stuart indicates. “Home health and hospice regulations are
purposely designed to make these two service lines entirely discrete
and discontinuous. Between them lies a chasm of unfilled need.”
In addition, a collection of exemplary hospital-based models appears in
Pioneer Programs in Palliative Care: Nine Case Studies, sponsored by RWJF
and Milbank Memorial Fund. In the report, clinicians at hospitals in
Alabama, Illinois, Massachusetts (two), New York (two), Ohio, Penn-
sylvania, and Virginia describe the establishment of palliative-care pro-
grams in their institutions.38
The developers of some of the models have been urging Congress and
CMS to develop a demonstration project so that they can test their ap-
proaches. This would mean waiving Medicare—and possibly Medicaid—
regulations, with the goal of making care of those with advanced illness
more continuous and bridging acute and end-of-life care.
COST AND PAYMENT CONSIDERATIONS
Medicare
In 2000, the last year for which data are available, the Medicare pro-
gram spent $224 billion for health services.39 While the Alliance for Ag-
ing Research has estimated that Medicare beneficiaries in the last year
of life account for over one-fourth of total Medicare expenditures,40 the
percentage of the total Medicare Part A budget spent on hospice (an
Just as there is a chasm
between “medical mod-
el” inpatient treatment
and the Medicare hos-
pice benefit, there is a
chasm between home
health and hospice.
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estimated $2.8 billion, or 1.3 percent) is quite small. (The estimated
amount for the limited Medicare skilled-nursing-facility [SNF] benefit
was $10.6 billion, or 4.9 percent. Home health accounted for $4.6 billion,
or 2.1 percent.) HCFA has indicated that, by percent of outlays, free-
standing hospice accounts for 55.5 percent, hospital-based programs 17.2
percent, SNFs 0.8 percent, and home health agencies 26.5 percent. A
1998 comparison of average charges per day in different settings indi-
cated $2,177 for hospital inpatient facilities, $482 for SNFs, and $113 for
hospice services.41 As noted earlier, only a small percentage of palliative-
care services are paid for under Medicare, because, by its very nature,
palliative care blurs Medicare’s structured payment boundaries.42
A lot of the research on end-of-life care has centered on studies compar-
ing expenditures for persons who elect hospice with those for people who
stay with intensive approaches, the health costs of the last year of life
with those of previous years, the health costs of persons 85 years of age
and older with those of people 65 to 84 years of age, the health costs of
one diagnosis with that of another, and similar studies. Because Medi-
care is the major payer of end-of-life care, whether in the acute or post-
acute setting, most of the studies use Medicare data, although some work
has been done on Medicaid and private insurance as well.
As indicated in other parts of this background paper, Medicare, as the
major payer of and model for hospice care, is the target of various criti-
cisms of the way it funds services for those with advanced illness, in-
cluding those who are dying. On one had, the program is criticized
because of the restrictions on the hospice benefit, primarily the require-
ments to waive standard Medicare benefits and to have a life expect-
ancy of less than six months. On the other hand, it is criticized for its
incentives for intensive acute services and its silos of post-acute services
that act as barriers to a seamless continuum in the last stages of life.
In recognition of the current debate over a Medicare outpatient pre-
scription-drug benefit, it is important to note the issue’s relevance to
hospice or palliative care. Because pharmaceuticals are so important to
the treatment of persons with advanced chronic illness, especially for
pain control and symptom management, they are central to the debate
over enactment of a prescription-drug benefit. While drugs are cov-
ered, along with necessary medical supplies, under the capitated Medi-
care hospice payment, they compete with work force costs, short-term
inpatient stays, and counseling for a share of the payment, according to
Tom Ault and Michael Hash, who recently analyzed Medicare prescription-
drug coverage issues in end-of-life care for Last Acts.43
Medicaid
Federal and state Medicaid spending for health services (without the
State Children’s Health Insurance Program) totaled $202 billion in 2000.44
Medicare is criticized
for its incentives for in-
tensive acute services
and its silos of post-
acute services that act
as barriers to a seam-
less continuum in the
last stages of life.
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A breakdown for 1998, the last year for which Medicaid hospice infor-
mation is available, indicates that hospice payments were $325 million,
or 0.2 percent of total spending. (“The federal share of Medicaid’s hos-
pice spending was $185.7 million, or 57.1 percent of the total FY 1998
Medicaid hospice payments,” according to HCFA’s Division of Medical
Statistics, as quoted on the Web site of the National Association for
Home Care.) Forty-four states offered the hospice option.45
As with other health services in this federal-state program, there was
considerable variation in the duration, amount, and scope of services,
according to Jane Tilly and Joshua Wiener, who analyzed Medicaid end-
of-life care for Last Acts. For example, “in 1998, the total number of
Medicaid hospice patients ranged from only 4 in Arizona to 7,583 in
Florida.”46 They identify three major payment issues:
First, according to most nongovernmental experts, the current hospice
rate for routine home care is too low to enable hospices to provide the
most advanced types of pain relief, such as chemotherapy and radiation
treatments. Another reason the payment level is considered low is that
hospices tend to serve patients in the last few weeks before death when
care can be particularly expensive and the payment rates do not ad-
equately adjust for case mix.
Second, payment rates are based on very old cost experience that no
longer reflects current expenses. Data from hospice demonstration
projects conducted during the early 1980s were used to calculate the
initial Medicare hospice rates, upon which both current Medicare and
Medicaid rates are based [The rates are periodically increased by an
update factor.]....
Third, the way in which Medicaid pays nursing homes for hospice
patients causes a great deal of confusion. In these circumstances, the
hospice is the primary caregiver for the resident and the nursing home
supplies room and board....State Medicaid programs must pay at least
95 percent of the nursing home rate for room and board directly to the
hospice, which in turn pays the nursing home....Reportedly, nursing
homes rarely accept less than 100 percent of the Medicaid room and
board payment. As a result, hospices generally pay full room and board
costs, which means that they suffer a financial loss.47
Private Insurance
Most private insurance plans offer hospice benefits, according to a 2000
study for DHHS by The MEDSTAT Group. The study used the
organization’s proprietary MarketScanR database, which includes ap-
proximately 70 employers and 200 insurance carriers and claims admin-
istrators (covering about four million privately insured persons). It showed
that 84.4 percent of indemnity plans, 90.0 percent of point-of-service (POS)
plans, and 100 percent of preferred-provider-organization (PPO) plans
offered a hospice benefit.
Most private insur-
ance plans offer hos-
pice benefits.
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However, when characteristics of the benefit were broken down by
indemnity, POS, and PPO, there was a great deal of variation. While the
great majority required precertification, only 55.6 percent of the indem-
nity, 66.7 percent of the POS, and 20.0 percent of the PPO plans included
a specified definition of terminal illness. Deductible and coinsurance pro-
visions varied significantly as well. Coverage for hospital-based hospice
services ranged from 81.5 percent of indemnity and 77.8 percent of POS
to only 40.0 percent of PPO plans, while in-home hospice coverage was
somewhat over or a little under 70 percent for all three types of plans. In
terms of covered services, the indemnity and POS plans were more lib-
eral than the PPO plans, across the board.48
While cost and payment considerations often override other issues in
health care debates, quality and cost seem to be on fairly even footing in
discussions on services for patients with “advancing” advanced illness,
who are near the end of life. While the field of end-of-life care was criti-
cized for years for not having hard data, public and private organizations
now generate a steady flow of studies and analyses, many funded by
philanthropy. Whether the aging of the population or attention to a con-
tinuum of services is bringing special urgency to the development and
acceptance of compassionate, cost-effective treatment plans for persons
with chronic advanced illness, the bell seems to be tolling for patients,
providers, payers—and policymakers—alike.
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